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Abstract
 
-
 
The Genetic risk prediction strategies found in 
practice for coronary artery disease are not significant to 
estimate the scope of adverse cardiovascular events such as 
unstable angina and myocardial infarction. Hence in regard to 
this objective, this manuscript contributed a metaheuristic 
approach to predict coro-
 
nary artery disease and the scope of 
unstable angina and myocardial infarction. The proposed 
metaheuristic is built from the gene expression data of blood 
samples collected from patients with coronary artery disease 
diagnosed, unstable angina and Myocardial Infarction. The 
data also includes gene expression data collected from the 
blood samples taken from the people clinically proven as 
salubrious (healthy). The relation between genes and gene 
expressions are considered as the state of input to devise the 
metaheuristic. In order to find the confidence of the relation 
between gene and gene expression a bipartite graph is built 
between them. The experimental study evincing that the 
prediction performance of the proposed model is substantial 
that compared to other benchmarking models.
 
Keywords:
 
micro array, coronary artery disease, unstable 
angina, myocardial infarction, gene expression data, 
gene expression profiling, metaheuristics, machine 
learning. 
 
I.
 
Introduction
 
ardiovascular diseases are the critical reason of 
human deaths happening worldwide. The statis-
 
tics indicating that this disease causes annually 
around 17.3 million deaths [1].The inadequate blood 
supply to the heart causes
 
necrosis of myocardial tiss-
 
ue, which is clinically referred as Myocardial Infarction 
(MI). 
 
The MI was claimed 7.6 million deaths among 
58 million deaths worldwide in 2005 [2].
 
The advan-
 
cements in clinical practices to diagnose and prevent MI 
are evinced to be not significant, since the count of 
human deaths due to MI is high that compared to the 
deaths caused by any other disease [1] [2].
 
The current diagnosis of MI is based on clinical 
symptoms including chest pain and difficulty to breath, 
ECG pattern variants, and potential drop and raise of 
blood floating in cardiac muscles (cardiac troponins 
also referred as cTns) [3]. Though the phenomenal 
advances in clinical diagnosis strategies found, still the 
substantial constraints are evinced in current clinical 
diagnosis strategies. The advances in hs-cTni assays 
[4] have evinced high detection of cardio vascular 
disease cases (Increased true positive rate) but 
significant normal cases have been labeled as cardio 
vascular prone (decreased true negative rate), which is 
a potential constraint. Another advanced approach of 
diagnose the cardio vascular disease diagnostic 
measure is the cardiac miRNAs as biomarkers [5]. The 
prediction outcomes of this model are trivial due to 
limited size and tissue specific expression. Hence it is 
obvious to have more significant and automated 
detection strategies, which are using the cardiac 
miRNAs as primary input [6]. The serum inflammatory 
markers such as BNP, CRP are also considered as 
cardiovascular biomarkers but the detection accuracy 
observed with slight improvement [7][8][9]. 
The acts such as clinical pathology and biology 
are the crucial to define cardiac biomarkers, which are 
expensive and less accurate. In contrast to this, the 
gene expression profiling quantifies the gene express- 
ions formed by the large quantity of genes in order to 
identify biomarkers, which is analogous and concurrent 
across the multiple pathways. Hence the gene expre- 
ssion profiling is potential and feasible to quantify the 
biomarkers to diagnose cardio vascular diseases [10]. 
The biomarkers defined by Gene expression profiling 
are potential and those are not evinced by the pathology 
and biology based clinical processes. 
The rest of manuscript describes the related 
work in section 2, the Metaheuristic Approach on Gene 
expression Data (MAGED) that followed by section 4, 
which elaborates the experimental study of the proposal. 
Finally the section 5 concludes the contribution of the 
manuscript. 
II. Related Work 
Gene expression analysis is a potential appro- 
ach to discover profound biomarkers of cardio vascular 
diseases. The contemporary literature contains signify- 
cant contributions in defining biomarkers through gene 
C
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expression analysis. Randi et al., [11] devised a gene 
expression analysis that conceded 482 genes 
associated to the composition of plaques found in 
arteries. Many of these genes were not considered for 
atherosclerosis in earlier diagnosis strategies. Archacki 
et al.,[12] proposed a gene expression profiling strategy 
that resulted 56 different genes for atherosclerosisprone 
and salubrious human coronary arteries. Among these 
56, the 49 genes were not associated to coronary artery 
disease earlier. The model devised in [13] discovered 
set of genes those enables classification according to 
age and sex, which are having strong association with 
obstreperous CAD in the patients, who are not 
diagnosed as diabetic. The contributions in [14] and 
[15] profiled variant gene expressions to differentiate the 
cardio myopathies with influence of ischemic and non-
ischemic conditions. Min KD et al., [16] contributed 
profiling and analysis of gene expressions to notice the 
divergent genes associated to congestive heart failure. 
Suresh R et al., [17] studied the salubrious and MI 
patients that discovered biomarkers and imbalanced 
pathways those significant evince the reappearance MI 
in patients effected once with MI. 
Liew et al.,[18] defined sequence tags from 
gene expressions using microarray analysis that 
compares mRNA molecules found in cellular 
components of the blood with mRNA molecules found 
in9divergent human tissues comprising heart. The 
correlation observed from this comparison concluded 
that 84% of mRNA molecules were overlapped with 
mRNA molecules of heart and 80% were overlapped 
with mRNA molecules of other tissues. mRNA molecules 
of cellular components of the blood are costing minimal 
and feasible to access in order to substitute gene 
expression in other tissues. 
The contributions found in contemporary 
literature are specific to discover the influential genes of 
Myocardial Infarction. None of these are capable to 
identify the given gene expression is prone to CAD 
under MI and UA or the expression is salubrious. This 
evinces the need of novel contributions to discover the 
state of a given gene expression is prone to CAD under 
MI and UA or salubrious. This helps to deploy the case 
based reasoning to treat the patients prone to CAD 
under MI and UA differently. In this regard this 
manuscript attempted to define metaheuristic approach 
on gene expression data (MAGED) to discover the state 
of a given gene expression is prone to CAD under MI 
and UA or salubrious.  The MAGED is machine learning 
strategy that learns from the labeled gene expression 
data of Cardia Vascular Diseased, Unstable Angina, 
Myocardial Infarction and Salubrious cases.
 
 
 
 
given gene expression data. In order to this the given 
gene expressions are partitioned into their respective 
categories of coronary artery disease (CAD), unstable 
angina (UA), Myocardial Infarction (MI) and salubrious 
(blood samples taken were diagnosed as healthy). The 
data also includes gene expression data collected from 
the blood samples taken from the people clinically 
proven as normal.
 
The genes involved in each gene expression 
are considered as features of the
 
respective category. 
Since the gene expression contains dense number of 
genes and majority of them may be insignificant to 
respective category of the disease. Henceforth, the 
feature optimization process (see sec 3.1) will be carried 
out to eliminate these insignificant features.
 
The gene 
range will be discretized further to compare two genes 
through equality by approximation (see sec 3.2). 
Afterwards the confidence of each feature towards all 
categories of gene expression data will be assessed 
(see sec 3.3) that follows the assessment of each gene 
expression confidence against the features of all 
categories (see sec 3.4). Further the confidence 
obtained for each feature and gene expression of 
respective category will be used as input to define the 
metaheuristic scales to estimate the scope of coronary 
artery disease, the unstable angina and myocardial 
infarction. 
 
a)
 
Feature Optimization
 
For each disease context considered, the gene 
expression dataset 1 2 | |{ ( ) , ( ) ,..... ( ) }ii DD e i e i e i=   of size 
| |iD
 
will be considered for training towards defining 
metaheuristic scale. Each gene expression is represent-
 
ted by sequence of genes for the set of features 
selected of respective diseases context. This description 
binds to all datasets ofgene expressions
 
representing 
coronary artery diseases, Unstable Angina, Myocardial 
Infarction.
 
Let 1 2 | |{ ( ) , ( ) ,..., ( ) }nn DD e n e n e n=
 
be the set of 
gene expressions collected from the blood samples of 
salubrious cases. The sets 1 2 | |{ ( ) , ( ) ,..., ( ) }ii FF f i f i f i=
 
and 1 2 | |{ ( ) , ( ) ,..., ( ) }nn FF f n f n f n=
 
are feature sets of 
gene expressions represented by iD
 
and nD
respectively. The attribute set 
1 2 | ( ) |( ) { ( ) , ( ) ,. . .( ) }jj G iG i g ij g ij g ij=
 
be the set of genes as 
values observed for feature ( ) jf i
 
of gene expressions 
represented by iD . Similarly the attribute set 
1 2 | ( ) |( ) { ( ) , ( ) ,. . .( ) }jj G nG n g nj g nj g nj=
 
be the set of genes 
III. Metaheuristic Approach on Gene 
Expression Data
The objective of the MAGED is to define a 
metaheuristic scale by the knowledge gained from the 
as values observed for feature ( ) jf n of gene 
expressions represented by nD .
Since the gene expression is the combination of 
numerous count of genes, the size of feature set can 
lead to process complexity. In order to overcome the 
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process complexity, the insignificant features should be 
identified and discarded. The feature ( ) jf i
 
of iF
 
is said 
to be insignificant feature, if genes ( ) jG i
 
of ( ) jf i
 
are 
almost similar to the genes ( ) jG n
 
of feature ( ) jf n
 
of nF
.Hence to identify the insignificant features, we adopt 
hamming distance that applied on genes of each 
feature as vectors from each disease and normal cases. 
The hamming distance with 0 or less than the given 
threshold indicates that the respective feature is 
insignificant. The process of hamming distance is 
explored below:
 
i.
 
Hamming Distance
 
The value of Hamming Distance obtained here 
is to denote the difference between genes assigned to 
same feature from gene expression data of diseased 
and normal cases. This is one of the significant strategy 
to assess the difference between to elements in coding 
theory. 
 
The hamming distance between given vectors 
1 2{ , ,.........., }nCX cx cx cx= & 1 2{ , ,........., }mCY cy cy cy=
 
of 
size n
 
and m
 
respectively will be measured as follows:
 
Let CZ φ←
 
// is a vector of size 0
 
{ 1, 2,3,.....max( . )}foreach i i n m∃ =
 
Begin
 
({ } { }) 0i i i iif  cx cx CX cy cy CY  then∃ ∈ − ∃ ∈ ≡
 
{ } { }i i i iCZ cx cx CX cy cy CY← ∃ ∈ − ∃ ∈
 
Else
 
1CZ ←
 
End
 
| |
1
{ }
CZ
CX CY
j
hd CZ i↔
=
= ∑
 
// CX CYhd ↔
 
is the hamming distance between CX and
CY
 
, { }CZ i
 
is the thi
 
element of the vector CZ
 
and 
| |CZ
 
is the size of the vector CZ
 
b)
 
Gene and Gene Expression Confidence Assessment
 
Then these genes found for each optimal 
feature of respective gene expression data set and the 
gene expressions of that data
 
set will be used further to 
assess the gene and gene expression confidence.
 
In order to this, initially the gene pairs will be 
defined such that each pair contains two genes and 
each gene representing different feature of the same 
dataset. Then we assess the associativity support of 
each gene pair. The associativity support can be 
described as the ratio of gene expressions contains that 
pair against the total number of gene expressions in 
respective dataset. The process of assessing 
 
  
 
 
 
 
 
 
 
 
Assessing Gene and Gene Expression Confidence
 
In order to assess the confidence of genes and 
gene expressions of respective gene expression
 
dataset
iD , a mutual relation graph will be formed between 
gene expressions and genes of respective iD . There will 
be an edge between a gene and gene expression if and 
only if the selected gene exists in that gene expression. 
Then each edge between gene and gene expression is 
weighted as follows. 
 
| ( )|
1
{ ( )}
G i
j jj
g g G i
=
∀ ∃ ∈ Begin
 
| |
1
{ ( ) ( ) }
lD
k j kk
e l g e l
=
∀ ∃ ∈ Begin
 
  
0
jg
w =
 
{ }
| ( ) |
1
( )
ke l
m m k j mm
g g e l g g
=
∀ ∃ ∈ ∧ ≠ Begin
 
{ , }m j mp g g=
 
  
( ) ( )j mw g s p+ =
 
 
          End
 
  
( )
( )
| ( ) | 1j k
j
g e l
k
w g
w
e l↔
=
−
 
 
End
 
End
 
The weights obtained for edges between genes 
and gene expressions in mutual graph are further used 
to assess the gene and gene expression confidence 
towards respective CAD (coronary artery disease), UA 
associativity support of each gene pair is described in 
following section (see sec 3.2.1).    
ii. Assessing gene pair correlation
Let iP be the set and contains all possible 
unique gene pairs from respective dataset iD . The 
possible unique gene pairs will found as follows: 
(unstable angina), MI (myocardial infarction) and Normal 
datasets.
Further we measure the each feature 
confidence towards gene expression dataset iD as 
follow
| ( )|
1
{ ( ) }
G i
j jj
g G i g
=
∀ ∃ ∋ Begin
| |
1
{ ( ) ( ) ( ) }
i
j i
D
g D j k j i k
k
c w g e i g D e i⇒
=
= ∃ ∋ ∧ ∋∑
© 2016   Global Journals Inc.  (US)
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iii.
For each gene expression ( ) je i of respective 
dataset iD , find all possible unique pairs of genes and 
add to iP . Then correlation of each pair{ }j j ip p P∃ ∈ as 
follows.
Let { }k k jg g p∃ ∈ and { }l l jg g p∃ ∈ be the two
genes paired as{ }j j ip p P∃ ∈ , then the correlation ( )js p
of the pair jp   is
| |
1
{1 { , } ( ) }
( )
| |
iD
k l v
v
i
i
g g e i
s p
D
=
∃ ⊆
=
∑
//The ratio of number of gene expressions contain both 
genesagainst total number of genes
The correlation of each pair of genes found in 
gene expressions of each respective gene expression 
data set of coronary artery disease, unstable angina, 
myocardial infarction and normal cases should be 
estimated using the process explored in sec 3.2.1.
  
 
  
 
//aggregating the weight of gene jg
 
towards each gene 
expression ( )ke i
 
of respective dataset iD and the same 
is considered as the respective gene confidence 
towards dataset iD
 
End
 
Similarly each respective gene expression 
confidence towards gene expression dataset iD
 
is
 
measured as follows
 
| |
1
{ ( ) ( ) }
iD
j i jj
e i D e i
=
∀ ∃ ∋
 
Begin
 
| ( )|
( )
1
{ ( ) ( ) ( ) }
j i k i
G i
e i D k g D j k i j
k
c w g c e i g D e i⇒ ⇒
=
= ⊗ ∃ ∋ ∧ ∋∑
 
//The sum of product of each gene weight and the 
respective gene confidence, such that the gene exists in 
selective gene expression is the confidence of that gene 
expression
 
End
 
The confidence of genes and gene expressions 
of each respective gene expression data set of CAD, 
UA, MI and salubrious cases should be estimated using 
the process explored in sec 3.2.2.
 
c)
 
Defining metaheuristics to CAD, UA, MI and 
Salubrious scope 
 
Further the confidence of gene expressions of 
gene expression datasets CADD , UAD , MID
 
and   
 
| |
( )
1
{ ( ) }
| |
CAD
i CAD
D
e CAD D CAD i
i
CAD
CAD
c D e CAD
m
D
⇒
=
∃ ∋
=
∑
 
//Aggregate 
mean of the respective
 
gene expressions confidence of 
coronary artery disease gene expression dataset CADD
 
In order to identify the lower and upper bounds of CADm , 
the mean absolute distance of CADD
 
is assessed as 
follows
 
( )
| | 2
( )
1
| |
CAD
i CAD
D
CAD e CAD D
ad i
CAD
CAD
m c
m
D
⇒
=
−
=
∑
 
Then the lower and upper bounds of CADm is
 
assessed as 
 
ad
CAD CAD CADml m m= −
 
// lower bound of CADm
 
ad
CAD CAD CADmu m m= +
 
// upper bound of CADm
 
 
 
 
 
The mean absolute distance of UAD
 
is
 
( )
| | 2
( )
1
| |
UA
i UA
D
UA e UA D
ad i
UA
UA
m c
m
D
⇒
=
−
=
∑
 
Then the lower and upper bounds of UAm is 
assessed as 
 
ad
UA UA UAml m m= −
 
// lower bound of UAm
 
ad
UA UA UAmu m m= +
 
// upper bound of UAm
 
| |
( )
1
{ ( ) }
| |
MI
i MI
D
e MI D MI i
i
MI
MI
c D e MI
m
D
⇒
=
∃ ∋
=
∑
 
//Aggregate 
mean of the respective gene expressions confidence of 
myocardial Infarction gene expression dataset MID
 
The mean absolute distance of MID
 
is
 
( )
| | 2
( )
1
| |
MI
i MI
D
MI e MI D
ad i
MI
MI
m c
m
D
⇒
=
−
=
∑
 
Then the lower and upper bounds of MIm is 
assessed as 
 
ad
MI MI MIml m m= −
 
// lower bound of MIm
 
ad
MI MI MImu m m= +
 
// upper bound of MIm
 
| |
( )
1
{ ( ) }
N
i N
D
e N D N i
i
N
N
c D e N
m
D
⇒
=
∃ ∋
=
∑
 
//Aggregate mean of 
the respective gene expressions confidence of 
salubrious gene expression dataset ND
 
The mean absolute distance of 
N
D
 
is
 
( )
| | 2
( )
1
| |
N
i N
D
N e N D
ad i
N
N
m c
m
D
⇒
=
−
=
∑
 
Then the lower and upper bounds of Nm is
 
assessed as 
 
ad
N N Nml m m= −
 
// lower bound of Nm
 
ad
N N Nmu m m= +
 
// upper bound of Nm
 
d)
 
Predicting the state of gene expression
 
The metaheuristics devised (see section 3.3) 
will be used further to assess the CAD, UA and MI 
scope of a given gene expression e . The confidence of 
given gene expression
 
Similarly metaheuristics for UA (unstable 
angina), MI (Myocardial infarction) and salubrious 
(healthy) scope 
| |
( )
1
{ ( ) }
| |
UA
i UA
D
e UA D UA i
i
UA
UA
c D e UA
m
D
⇒
=
∃ ∋
=
∑
//Aggregate 
mean of the respective gene expressions confidence of 
Unstable Angina gene expression dataset UAD
{ }
{ }
| ( )|
1
| ( )|
1
( ) ( )
( ) ( )
CAD
i
CAD
j
G D
g CAD i i CAD i
i
e CAD G D
g CAD j j CAD
j
c w g g G D e g
c
c w g g G D
⇒
=
⇒
⇒
=
⊗ ∃ ∈ ∧ ∋
=
⊗ ∃ ∈
∑
∑
// the aggregate of product of each gene confidence 
and weight of that exists in ( )CADG D and e , which 
divides by the aggregate of confidence of all genes 
exists in ( )CADG D
.
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Further the confidence of e
 
towards UAD , MID
 
and ND
 
assessed as :
 
{ }
{ }
| ( )|
1
| ( )|
1
( ) ( )
( ) ( )
i
j
G UA
g UA i i i
i
e UA G UA
g UA j j
j
c w g g G UA e g
c
c w g g G UA
⇒
=
⇒
⇒
=
⊗ ∃ ∈ ∧ ∋
=
⊗ ∃ ∈
∑
∑
 
// the aggregate of product of each gene confidence 
and weight of that exists in ( )UAG D
 
and e , which divides 
by the aggregate of confidence of all genes exists in
( )UAG D .
 
{ }
{ }
| ( )|
1
| ( )|
1
( ) ( )
( ) ( )
i
j
G MI
g MI i i i
i
e MI G MI
g MI j j
j
c w g g G MI e g
c
c w g g G MI
⇒
=
⇒
⇒
=
⊗ ∃ ∈ ∧ ∋
=
⊗ ∃ ∈
∑
∑
 
// the aggregate of product of each gene confidence 
and weight of that exists in ( )UAG D
 
and e , which divides 
by the aggregate of confidence of all genes exists in
( )UAG D .
 
{ }
{ }
| ( )|
1
| ( )|
1
( ) ( )
( ) ( )
i
j
G N
g N i i i
i
e N G N
g N j j
j
c w g g G N e g
c
c w g g G N
⇒
=
⇒
⇒
=
⊗ ∃ ∈ ∧ ∋
=
⊗ ∃ ∈
∑
∑
 
// the aggregate of product of each gene confidence 
and weight of that exists in ( )UAG D
 
and e , which divides 
by the aggregate of confidence of all genes exists in
( )UAG D .
 
Then these confidence values of gene 
expression e
 
with respect to CAD ,UA , MI and N
 
will 
be used to estimate the given expression state is 
salubrious, prone to coronary artery disease, Unstable 
Angina or Myocardial Infarction according to the 
following conditions.
 
 
  
( ) ( ) ( )e CAD CAD e UA UA e MI MIc m c ml c ml⇒ ⇒ ⇒≥ ∧ ≥ ∧ ≥
 
Coronary Artery Disease Confirmed (prone to 
CAD
 
and either or both of the UA
 
and MI )
 If 
( )
( )
( )
( )
e CAD CAD
e UA UA
e MI MI
e N MI
c ml
c ml
c ml
c m
⇒
⇒
⇒
⇒
≥ ∧ 
 ≥ ∧ 
 ≥ ∧
  < 
 Then
 
Prone
 
to Coronary Artery Disease
 if 
( )
( )
( )
( )
e CAD CAD
e UA UA
e MI MI
e N MI
c ml
c ml
c ml
c m
⇒
⇒
⇒
⇒
< ∧ 
 < ∧ 
 < ∧
  > 
 Then Salubrious state Confirmed
 if 
( )
( )
( )
( )
e CAD CAD
e UA UA
e MI MI
e N MI
c m
c m
c m
c mu
⇒
⇒
⇒
⇒
< ∧ 
 < ∧ 
 < ∧
  ≥ 
 Then Prone to Salubrious state
 
IV.
 
Experimental Study
 
The experimental study was carried out on a set 
of gene expressions taken from multiple benchmark 
datasets [19]. The number of gene expressions used 
are 1114, which are the combination of coronary artery 
Disease (286 expressions), Unstable Angina (275 
expressions), Myocardial Infarction (277 expressions) 
and salubrious condition (276
 
expressions). The gene 
expressions of respective category are considered as 
separate datasets labeled as CADD , UAD , MID and ND . 
Each dataset CADD , UAD , MID and ND
 
partitioned into 
test and training sets. The 75% of gene expressions of 
each dataset are considered as training set and rest 
25% of gene expressions considered as test set.
 
 
    
Training Set
 
834 (CAD:214, UA:206,MI:207, N:207)
 
CADm
 
0.582474187
 
ad
CADm
 
0.095593654
 
CADml
 
0.486880533
 
CADmu
 
0.678067841
 
UAm
 
0.615957277
 
ad
UAm
 
0.103864099
 
( ) ( ) ( )e CAD CAD e UA UA e MI MIc mu c mu c mu⇒ ⇒ ⇒≥ ∨ ≥ ∨ ≥
Coronary Artery Disease Confirmed (highly 
prone to either of three disease conditions)
UAml 0.512093178
UAmu 0.719821376
© 2016   Global Journals Inc.  (US)
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Table 1: The metaheuristics obtained from training data
The metaheuristics obtained from the given 
training set were explored in table 1.
  
  
  
  
MIml
 
0.546916686
 
MImu
 
0.74636102
 
Nm
 
0.631593026
 
ad
MIm
 
0.068999373
 
Nml
 
0.562593653
 
Nmu
 
0.700592398
 
   
Test Set
 
280 (CAD:72, UA:69,MI:70, N:69)
 
True Positives
 
197
 
True Negatives
 
54
 
False Positives
 
15
 
False Negative
 
14
 
CAD, UA and MI gene expression Prediction Value
 
(positive prediction value, PPV)
 
0.929245283
 
Salubrious gene expression Prediction Value
 
(Negative Prediction
 
value, NPV)
 
0.794117647
 
Detection Accuracy
 
0.896428571
 
AD, UA and MI gene expression prediction Rate
 
(True Positive Rate)
 
0.933649289
 
Salubrious gene expression Prediction rate
 
(True Negative Rate)
 
0.782608696
 
Figure
 
1:
 
The prediction statistics observed for MAGED
 
The 280 (CAD: 72, UA: 69, MI: 70, N: 69) gene 
expressions were used to assess the prediction 
accuracy of the proposed MAGED. The
 
MAGED assess-
 
ed the given input gene expressions such that 197gene 
expressions are true positives (the detection of CAD, UA 
and MI gene expressions are true), 15gene expressions 
are false positive (falsely detected as CAD, UA or MI), 
54gene expressions are true negatives (detecting gene 
expressions as salubrious is true) and 14gene expre-
 
ssions
 
are false negative (detecting gene expressions 
as salubrious is false). Hence the CAD, UA or MI gene 
Expression prediction value is 0.79, the CAD, UA and 
MIgene expression detection rate (also known as 
sensitivity) is 0.93, the salubrious gene expression dete-
 
ction rate (also known as specificity) is 0.782 and the 
overall success rate (also known as accuracy, which is 
the ratio between true prediction of all types of gene 
expressions and all given number of gene expressions) 
is 0.90. These statistics indicating that the MAGED is 
find to significant to identify the CAD, UA and MI prone 
expression prediction value (also known as precision or 
positive prediction value) is 0.93, Salubrious Gene 
gene expressions with success percentage of 93% 
(since sensitivity is 0.93), but the detection of salubrious 
cases, the success rate is 78% (since specificity is 
0.782). The computer aided medical diagnosis should 
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Table 2 : The prediction statistics of the SDS
be more robust to deliver high sensitivity at the cost of 
specificity. Hence the Model MAGED is scalable and 
robust to predict the CAD, UA and MI prone gene 
expressions.The prediction statistics observed from the 
experimental study of the MAGED are visualized in fig1.
 
V.
 
Conclusion
 
This paper introduced a learning model that 
device heuristics to scale the given patient record is 
disease prone or normal. The proposed learning model 
delivers two heuristics called Scale to Diseased health 
Scope and Scale to Normal Health Scope.
 
In contrast to 
the existing benchmarking models, these heuristics are 
further used as scales to assess the given patient record 
is disease prone or normal. The medical records labeled 
as diseased and normal are used to device the 
heuristics and respectively.  In order to this 
all unique values of all the attributes are considered as 
features, and then the influence weight of these features 
towards their respective datasets. The influence weights 
further will be used to assess the influence weight
 
of the 
each record in dataset. From these influence weights of 
the records of respective dataset will be used to assess 
the proposed heuristics. The experimental results are 
optimistic and concluding the prediction accuracy and 
robustness. This work can be extended to identify the 
impact of feature correlation towards minimizing the 
process and computational complexity of the learning 
process.
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